On July 28, 2025 oNKo-innate reported that it has grown from a pioneering NK cell biology startup into a fully integrated biotechnology company with global ambitions. Today, we are proud to introduce our new name: Audax Biosciences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Audax captures the spirit that has driven our founders from day one. Inspired by a passion for long distance endurance cycling, the name symbolises persistence, discipline, and the unwavering commitment required to create medicines that make a meaningful difference. Just as an audax ride tests skill and endurance, advancing breakthrough therapies demands resilience, precision, and long term vision.

Audax Biosciences reflects both our heritage and our ambition – a company built to endure, innovate, and deliver impactful medicines for patients worldwide.

(Press release, Audax Biosciences, JUL 28, 2025, View Source [SID1234665871])